The abnormal expression of USP30-AS1 has been widely reported, such as in cervical cancer, glioblastoma, ovarian cancer, bladder urothelial carcinoma, and cutaneous melanoma [17–21]. This evidence concerns the gene USP30 and ovarian cancer.